Gastroesophageal reflux disease and sleep disturbances
- 958 Downloads
Nighttime reflux during sleep plays a crucial role in several conditions associated with gastroesophageal reflux disease (GERD). Reflux patterns during arousal and sleep are different because of delayed gastric emptying, reduced esophageal peristalsis, decreases in swallowing and salivary secretion, and prolonged esophageal clearance during sleep. Clinical evidence strongly suggests that GERD is associated with sleep disturbances such as shorter sleep duration, difficulty falling asleep, arousals during sleep, poor sleep quality, and awakening early in the morning. New mechanisms on how GERD affects sleep have been recently identified by using actigraphy, and sleep deprivation was found to induce esophageal hyperalgesia to acid perfusion. Thus, the relationship between GERD and sleep disturbances is bidirectional. Among lifestyle modifications, avoidance of a late night meal plays a role in prevention of nighttime reflux. Treatment with a proton pump inhibitor (PPI) improves both nighttime symptoms and subjective sleep parameters, but its effects on objective sleep parameters remain unclear. Better control of nighttime acid secretion by administering a PPI at different times or by providing a double-dose PPI, adding H2 receptor antagonists, or other new agents is proposed. The effects of such treatments on sleep disturbances remain to be elucidated. GERD patients with sleep disturbances report more severe symptoms and poorer quality of life as compared to those without sleep disturbances. Consequently, GERD should also be classified as GERD with sleep disturbance and GERD without sleep disturbance.
KeywordsGastroesophageal reflux disease Sleep disturbance Proton pump inhibitor Quality of life
Conflict of interest
Yasuhiro Fujiwara received honoraria for lectures for Eisai. Tetsuo Arakawa received a research grant, received honoraria, and serves as a consultant to Otsuka Pharmaceutical and Eisai. Ronnie Fass is a consultant for Takeda and Vecta, speaker for Takeda, and received a grant from AstraZeneca and Reckitt Benckiser.
- 2.Czeisler CA, Winkelman JW, Richardson GS. Sleep disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, editors. Harrison’s principles of internal medicine. 17th ed. New York: McGraw Hill Medical; 2008. p. 171–80.Google Scholar
- 4.The Gallup Organization. A Gallup Organization National Survey: HB Across America. Princeton. 1998, 2000.Google Scholar
- 8.Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487–93.PubMedCrossRefGoogle Scholar
- 19.Reinberg A, Smolensky MH. Biological rhythms and medicine: cellular, metabolic, physiopathologic, and pharmacologic aspects. New York: Springer; 1983.Google Scholar
- 36.Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Sasaki E, Watanabe T, et al. Association between sleep duration and gastroesophageal reflux disease. Jpn Gastroenterol. 2005;128:A384 (abstract).Google Scholar
- 46.Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Standards of Practice Committee; American Academy of Sleep Medicine, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007;30:519–29.PubMedGoogle Scholar
- 56.Pehlivanov ND, Olyaee M, Sarosiek I, McCallum RW. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther. 2003;18:883–90.PubMedCrossRefGoogle Scholar